The Animal Health Biotechnology industry has experienced strong growth during the past five years. Industry growth is largely fueled by R&D expenditure, which has increased during the past five years. Moreover, economic conditions have improved in many of the industry's downstream foreign markets, such as the European Union. In the coming years, industry growth will be positively impacted by recent Food and Drug Administration announcements regarding food safety and cloning. Furthermore, public and private R&D expenditure is expected to increase.
The Animal Health Biotechnology industry researches, develops, tests and distributes therapeutic drugs, diagnostic tools and preventive products for livestock and companion animals. Drugs that are not developed using biological materials or processes are not included in this industry. In addition, companies provide tools that aim to improve farm animal breeding programs.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.